Company Information

CIN
Status
Date of Incorporation
09 February 2010
State / ROC
Bangalore / ROC Bangalore
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
37,000,000
Authorised Capital
40,000,000

Directors

Vasudevan Sathyamoorthy
Vasudevan Sathyamoorthy
Director/Designated Partner
about 3 years ago
Kushboo Ranka
Kushboo Ranka
Director/Designated Partner
over 3 years ago
Palaniandy Krishnamurthy .
Palaniandy Krishnamurthy .
Director/Designated Partner
about 4 years ago
Vijay Kumar Ranka
Vijay Kumar Ranka
Managing Director
over 8 years ago
Medipalli Sreehari .
Medipalli Sreehari .
Director
almost 12 years ago

Past Directors

Uday Chandrashekhar Shetty
Uday Chandrashekhar Shetty
Director
almost 16 years ago
Suresh Khanna
Suresh Khanna
Director
almost 16 years ago

Patents

Novel Lozenges Formulation

A Novel Solid oral lozenges pharmaceutical compositions comprises Flurbiprofen.

Novel Lozenges Formulation

This present invention relates to a troche composition which imparts a favorable oral sensation Further the invention relates to novel the torche formulation which contains Cetylpyridinium chloride.

Novel Lozenges Formulation

This present invention relates to a troche composition which imparts a favorable oral sensation. Further the invention relates to novel the torche formulation which contains Dichlorobenzyl alCohol, Benzydamine and Lignocaine

Novel Lozenges Formulation

This present invention relates to a Lozenges (troche) composition which imparts a favorable oral sensation. Further the invention relates to novel the torche formulation which contains Benzocaine.

Novel Lozenges Formulation

ABSTRACT: This present invention relates to a troche composition which imparts a favorable oral sensation. Further  the  invention  relates  to  novel  the  torche  formulation  which  contains Dextromethorphan Hydrobromide.

Novel Lozenge Formulation Which Contains Combination Of Dichlorobenzyi Alcohol And Amylmetacresol.

ABSTRACT: This present invention relates to a troche composition which imparts a favorable oral sensation. Further the invention relates to novel the torche formulation which contains Dichlorobenzyl alcohol and Amylmetacresol.

Novel Lozenges Formulation

ABSTRACT: This present invention relates to a troche composition which imparts a favorable oral sensation. Further the invention relates to novel the torche formulation which contains Hexylresorcenol and Benzalkonium chloride. The conventional troches impart coarse and powdery feelings, and thus are not ...

A Method And Orally Disintegrable Pharmaceutical Composition For Cholecalciferol

An orally disintegrable pharmaceutical composition for rapid release and increased bioavailability of a drug comprising a cholecalciferol (410) that acts as an active ingredient of the drug, a propylene glycol (430) to stabilize the active ingredient, a polyethylene glycol (PEG) (420) as an excipient of the drug, an...

Method And Composition For Removal Of Nicotine Odour From Smoke

Method and Composition for Removal of Nicotine Odour from Smoke ABSTRACT A biodegradable composition (201) for removal of nicotine odour comprising benzoin tincture (210) as a scrubbing agent, tolu balsam (220) as a flavouring agent, sodium hydroxide (230) as a neutralizer and sodium bicarbonate (240) as a reducin...

Curcumin Compositions And Process For Preparing Same

ABSTRACT FORMULATION COMPRISING WATER SOLUBLE PARTICLES OF A NON-CURCUMINOID AND A CURCUMINOID Embodiments relate to a formulation comprising a particle comprising a turmeric oleoresin or a curcumin removed turmeric oleoresin or a turmeric oil or combination thereof wherein the composition is water-soluble and the...

A Method And Composition For Transdermal Drug Delivery In Animals For Osteoarthritis

A METHOD AND COMPOSITION FOR TRANSDERMAL DRUG DELIVERY IN ANIMALS FOR OSTEOARTHRITIS ABSTRACT A pharmaceutical composition (310) for penetration of water-insoluble boswellia saratta extracts (410) into skin comprising 0.1% (w/w) of boswellia sarrata extracts (410) as an anti-inflammatory agent, 0.005% (w/w) of cap...

Stable Oral Solution Formulation Comprising Ultra Fine And Fine Particles Of Vitamin D3, A Curcuminoid And A Non Curcuminoid

ABSTRACT STABLE ORAL SOLUTION FORMULATION COMPRISING ULTRA-FINE AND FINE PARTICLES OF VITAMIN D3, A CURCUMINOID AND A NON-CURCUMINOID The present invention generally relates to the field of pharmaceutical preparation. More particularly present invention relates to stable clear uniformly interspersed particle oral so...

Novel Topical Cream Compositions For Diabetic Foot Treatment And Process For Preparation Thereof

ABSTRACT NOVEL TOPICAL CREAM COMPOSITIONS FOR DIABETIC FOOT TREATMENT AND PROCESS FOR PREPARATION THEREOF The present invention relates to topical compositions for Diabetic foot treatment. The present invention specifically relates to novel topical cream composition comprising Curcuma nano drop and pharmaceuti...

Novel Liver Health Composition And Process For Preparation Thereof

ABSTRACT NOVEL LIVER HEALTH COMPOSITION AND PROCESS FOR PREPARATION THEREOF The present invention relates to a composition comprising Curcuma Nanodrop, Silymarin and N-acetyl L-cysteine. The present invention relates to composition comprising Curcuma Nanodrop, Silymarin and N-acetyl L-cysteine for liver health. ...

Registered Trademarks

En Infi Nano Technology Logo Stabicon Life Sciences

[Class : 42] Development Of Technology For Manufacturing Pharmaceuticals And Nutraceuticals.[Class : 45] Licensing Of Techchnology For Manufacturing Pharmaceuticals And Nutraceuticals.

Zuicel Augmented Systemic Delivery Stabicon Life Sciences

[Class : 42] Scientific And Technological Services And Research And Design Relating Thereto; Industrial Analysis, Industrial Research And Industrial Design Services; Quality Control And Authentication Services; Design And Development Of Computer Hardware And Software

Cd4 Shield Stabicon Life Sciences

[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Human Beings And Animals; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungi...

Charges

4 Crore
28 February 2011
State Bank Of India
3 Crore
26 September 2020
Icici Bank Limited
27 Lak
28 February 2011
State Bank Of India
0
26 September 2020
Others
0
28 February 2011
State Bank Of India
0
26 September 2020
Others
0
28 February 2011
State Bank Of India
0
26 September 2020
Others
0

Documents

Instrument(s) of creation or modification of charge;-12102020
Form CHG-1-12102020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20201012
Form MSME FORM I-03102020_signed
Form DPT-3-18052020-signed
Form MGT-7-24122019_signed
List of share holders, debenture holders;-20122019
Form AOC-4(XBRL)-08122019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-06122019
Form MSME FORM I-31102019_signed
Form ADT-1-17102019_signed
Copy of the intimation sent by company-14102019
Copy of written consent given by auditor-14102019
Copy of resolution passed by the company-14102019
Form BEN - 2-26082019_signed
Declaration under section 90-26082019
Form DPT-3-01072019
Form ADT-1-12062019_signed
Copy of the intimation sent by company-12062019
Copy of resolution passed by the company-12062019
Copy of written consent given by auditor-12062019
Form MSME FORM I-30052019
Form CHG-1-18052019_signed
Instrument(s) of creation or modification of charge;-18052019
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20190518
Form INC-22-10052019_signed
Copies of the utility bills as mentioned above (not older than two months)-10052019
Optional Attachment-(1)-10052019
Proof of Registered Office address(Conveyance/Lease deed/Rent Agreement along with the rent receipts) etc-10052019
Form MGT-7-15012019_signed